Patent ID: 11944611
Assignee: GILEAD SCIENCES, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating human immunodeficiency virus (HIV) infection in a heavily treatment-experienced patient, the method comprising administering to the patient a therapeutically effective amount of a pharmaceutical composition comprising a sodium salt of the compound of Formula (Ia):, one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition is in the form of a solution comprising about 10 w/w % to about 40 w/w % water, about 35 w/w % to about 75 w/w % polyethylene glycol 300 (PEG 300), and about 5 w/w % to about 35 w/w % of the sodium salt of the compound of Formula (Ia);
wherein the HIV infection is an HIV-1 infection characterized by HIV-1 mutant resistance to one or more antiretroviral medications.